Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2024 Earnings Call Transcript
Megan LeDuc: Good evening, I’m Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I’m joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
Ginkgo Bioworks Holdings Inc. (DNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 4. | Ghisallo Capital Management Michael Germino | 0 | $0 | 0% | |
| 5. | Davidson Kempner Thomas Lenox Kempner | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.82 | 625,000 | Director | 2,356,874 | 2024-05-15 | Filing | |
| $0.91 | 297,619 | Director | 718,540 | 2024-05-14 | Filing | |
| $1.28 | 400,000 | Director | 1,731,874 | 2023-05-18 | Filing | |
| $1.28 | 350,000 | Director | 420,921 | 2023-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.33 | 13,520 | Officer | 195,058 | 2024-07-02 | Filing | |
| $0.33 | 49,162 | Officer | 1,043,626 | 2024-07-02 | Filing | |
| $0.55 | 13,440 | Officer | 178,832 | 2024-06-03 | Filing | |
| $0.55 | 48,866 | Officer | 984,662 | 2024-06-03 | Filing | |
| $0.83 | 265,000 | Director | 5,515,364 | 2024-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
16 Best US Stocks To Invest In Under $10
In March 2024, the S&P 500 surged with a total return of 3.2%, marking the first quarter's closure with a record high not seen since 2019.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2023 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.09 EPS, expectations were $-0.09. Ginkgo Bioworks Holdings, Inc.
12 Best NYSE Penny Stocks To Buy
Markets wavered as latest data showed inflation in January 2024 was hotter-than-expected.
5 Hot Healthcare Stocks To Buy Now
In this article, we will be taking a look at 5 hot healthcare stocks to buy now.
Ark Invest Stock Portfolio: 16 Biggest Positions
In this article, we discuss the 16 biggest positions in the ARK Invest portfolio.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2023 Earnings Call Transcript
Megan LeDuc: Good evening. I'm Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
15 Best ARK Stocks To Buy Now
Cathie Wood’s flagship ARK Innovation ETF made a roaring comeback earlier this year when investors’ risk appetite increased and growth stocks rebounded.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Billionaire Hedge Funds
